The opportunity
Rare founding-team seat, high autonomy, direct access to the CEO and Board, and the chance to shape a pan-regional sourcing function from scratch
This is a newly created role. You will lead in-licensing origination across APAC, with a strong emphasis on China’s fast-growing biotech ecosystem. You will partner directly with the CEO and a small senior team, alongside a Europe-based BD counterpart, to build a continuously refreshed funnel of differentiated early-to-mid-stage assets and convert it into signed transactions.
What you’ll do
- Source and originate in-licensing opportunities for differentiated early-to-mid-stage assets across APAC
- Build and maintain a high-quality pipeline aligned to portfolio strategy and risk/return criteria
- Lead early scientific and commercial screening, working with clinical and project leads on deeper diligence
- Support deal structuring and negotiation with the COO and external counsel
- Represent the company at partnering events, conferences and scientific forums across the region
- Prepare recommendations for portfolio review and Board discussions
What you bring
- Senior BD, licensing or corporate development experience in biotech or pharma
- A strong, active network across APAC, especially in China
- A track record of sourcing and closing in-licensing, out-licensing or M&A deals for early-to-mid-stage assets
- The scientific fluency to credibly screen assets across therapy areas and modalities
- Comfort in a lean, high-velocity platform rather than a large BD organisation
- Professional proficiency in Mandarin is strongly preferred to support business development, partner engagement and negotiations with Chinese biotech companies. Candidates must be based in Singapore or willing to relocate to Singapore.
- An entrepreneurial, self-directed mindset and cultural fluency across Western institutional and Asian biotech ecosystems
AM
Reg. No. R1110770
BeathChapman Pte Ltd
Licence no. 16S8112
